Prolevi Bio
Effective treatment of hypothyroid
- CEO: Sahil Gupta
- First investment year: 2022
- Fund: South
- Business sector: Life Science
Prolevi Bio develops a delayed release thyroid hormone formulation mimicking the circadian rhythm improving long-term side effects, overdosing and patient compliance.